Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRCP | P42785 | 3/20 | 0.89 |
| ▸ | NAAA | Q02083 | 1/20 | 0.63 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.55 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.55 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.55 |
| ▸ | TLR2 | O60603 | 2/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 9/20 | 0.52 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5898615 | 0.98 | PRCP (0.91) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL3231149 | 0.97 | PRCP (0.88) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL2792169 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL5898619 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL7955918 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL9825221 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL16618490 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL11842693 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| SCHEMBL2983853 | 0.94 | PRCP (1.00) | PRCPNAAAGNAI3GNAO1GNAI1 | |
| Hydrochloric Acid SCHEMBL7769069 | 0.93 | PRCP (0.97) | PRCPNAAAGNAI3GNAO1GNAI1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060165648-A1 | Compounds, compositions, and methods for controlling biofilms | DEGENHARDT CHARLES R | 2006-07-27 | — | — | US | disclosed |
| US-7018642-B2 | Compounds, compositions, and methods for controlling biofilms | THE PROCTER & GAMBLE COMPANY (US) | 2006-03-28 | — | — | US | disclosed |
| US-20030105072-A1 | Compounds, compositions, and methods for controlling biofilms | THE PROCTER & GAMBLE COMPANY | 2003-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060165648-A1 | Compounds, compositions, and methods for controlling biofilms | BMP2, BMP1, BMP4 | PRCP 3054/4885NAAA 105/4885GNAI3 2675/4885 |
| US-20030105072-A1 | Compounds, compositions, and methods for controlling biofilms | BMP2, BMP1, BMP4 | PRCP 3054/4885NAAA 105/4885GNAI3 2675/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.